Ilana Schlam, Breast medical oncologist at Dana-Farber Cancer Institute, shared on X:
“With 6 FDA approvals in breast cancer already in 2026, it was time to update the breast cancer treatment algorithms. It’s a great problem to have when innovation is moving so fast that it’s hard to keep up.”
You might be interested in:
TROPION-Breast01 Details Dato-DXd Safety and Patient-Reported Outcomes
